Generating appropriate clinical data for value assessment of medical devices: what role does regulation play?. (October 2014)

• Record Type: Journal Article
• Authors: Tarricone, Rosanna; Torbica, Aleksandra; Ferré, Francesca; Drummond, Mike
• Is Part Of: Expert review of pharmacoeconomics & outcomes research. Volume 14:Number 5(2014)
• Page Start: 707
• Page End: 718
• Publication Date: 2014-10
• Subjects: Pharmacology -- Economic aspects -- Periodicals; 338.47615105
• DOI: 10.1586/14737167.2014.950233
• Languages: English
• ISSNs: 1473-7167

Abstract

<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <p>Assessing the value of health technologies, through health technology assessment is critically dependent on the existence of relevant and robust clinical data on the efficacy, safety and ideally, effectiveness of the technologies concerned. However, in the case of medical devices, such clinical data may not always be available, because of the different nature of the regulatory requirements in different jurisdictions. Therefore, we conducted a systematic review of the regulatory requirements in seven major jurisdictions in order to identify current challenges and to suggest possible improvements. There are differences in the requirements across jurisdictions and in the balance between pre-market and post-market controls. Several improvements are required in order to generate adequate clinical data for health technology assessment.</p> </abstract>